Get started
Author

Kevin G. Pollock

Observed names: K Pollock, K.G. Pollock, Kevin G Pollock, Kevin Pollock, Pollock, Kevin G, Pollock, Kevin G.
ORCID: 0000-0001-5298-0504
Observed ORCID: 0000-0001-5298-0504
OpenAlex ID: A5036560935
Meta-Analysis Comparing Apixaban Versus Rivaroxaban for Management of Patients With Nonvalvular Atrial Fibrillation
2021 · Mamas A. Mamas, Sarah Batson, et al. · The American Journal of Cardiology · 44
The association between brain volume loss and disability in multiple sclerosis: A systematic review
2023 · Paul M. Matthews, Digant Gupta, et al. · Multiple Sclerosis and Related Disorders · 43
Sex Differences in Oral Anticoagulation Therapy in Patients Hospitalized With Atrial Fibrillation: A Nationwide Cohort Study
2023 · Kuan Ken Lee, Dimitrios Doudesis, et al. · Journal of the American Heart Association · 32
PDF
Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014–2019)
2022 · Mark Joy, John Williams, et al. · Heart · 30
Identification of undiagnosed atrial fibrillation using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI) in primary care: cost-effectiveness of a screening strategy evaluated in a randomized controlled trial in England
2022 · Nathan R. Hill, Lara Groves, et al. · Journal of Medical Economics · 29
Budget impact analysis of a machine learning algorithm to predict high risk of atrial fibrillation among primary care patients
2022 · Tomasz Szymanski, Rachel Ashton, et al. · EP Europace · 26
PDF
Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trial
2020 · Nathan R. Hill, Chris Arden, et al. · Contemporary Clinical Trials · 25
PDF
Highly VirulentEscherichia coliO26, Scotland
2011 · Kevin Pollock, Sheetal Bhojani, et al. · Emerging infectious diseases · 24
PDF
A Novel Risk Prediction Score for Clinically Significant Bleeding in Patients Anticoagulated for Venous Thromboembolism with Active Cancer
2023 · Alexander T. Cohen, Christopher Wallenhorst, et al. · Thrombosis and Haemostasis · 21
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational study
2021 · Ernest Choy, Lara Groves, et al. · BMC Rheumatology · 11
PDF
Major variation in hepatocellular carcinoma treatment and outcomes in England: a retrospective cohort study
2022 · Sue Beecroft, Matthew O’Connell, et al. · Frontline Gastroenterology · 9
Delay and Pay? Healthcare Costs Associated with Late Oral Anti-coagulant Prescribing in People with Atrial Fibrillation
2024 · Ryan J. Mulholland, Giorgio Ciminata, et al. · PharmacoEconomics · 5
Evaluating the effect of inequalities in oral anti-coagulant prescribing on outcomes in people with atrial fibrillation
2024 · Ryan J Mulholland, Francesco Manca, et al. · European Heart Journal Open · 5
PDF
An Update on Anti-thrombotic Therapy Following Transcatheter Aortic Valve Implantation: Expert Cardiologist Opinion from a UK and Ireland Delphi Group
2023 · Azfar Zaman, Bernard Prendergast, et al. · Interventional Cardiology Reviews Research Resources · 5
PDF
Clinical profile of patients with comorbid IBD and MS, and associated service impact in England’s secondary care setting: a retrospective cohort study
2025 · Baptiste Coxam, Faisal Sheikh, et al. · BMJ Open · 2
Clinical surveillance of haemolytic uraemic syndrome 2003-2009: renal prognosis at three-year follow up.
2010 · Kevin G. Pollock, David Young · 2
A novel dynamic risk score to predict venous thromboembolism recurrences after 3 months of anticoagulation in patients with incident venous thromboembolism and without active cancer
2026 · Alexander T. Cohen, Satarupa Choudhuri, et al. · Journal of Thrombosis and Haemostasis · 1
A novel dynamic risk score to predict clinically significant bleeding after 3 months of anticoagulation in patients with incident venous thromboembolism and without active cancer
2026 · Satarupa Choudhuri, Alexander T. Cohen, et al. · Journal of Thrombosis and Haemostasis · 1
Undertaking multi-centre randomised controlled trials in primary care: learnings and recommendations from the PULsE-AI trial researchers
2024 · Kevin G. Pollock, Carissa Dickerson, et al. · BMC Family Practice · 1
PDF
A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK
2023 · Alexander T. Cohen, Gary Benson, et al. · Current Medical Research and Opinion · 1
PDF
Sex-differences in oral anticoagulation therapy in patients hospitalised with atrial fibrillation: a nationwide cohort study
2022 · K Lee, D Doudesis, et al. · European Heart Journal · 1
PDF
Enhanced surveillance of thrombotic microangiopathies in Scotland, 2003-2008.
2009 · Kevin G. Pollock, Mary E. Locking, et al. · 1
Inequalities in oral anticoagulant treatment patterns: a two-part model to estimate healthcare costs associated with atrial fibrillation
2026 · Giorgio Ciminata, Ryan J. Mulholland, et al. · The European Journal of Health Economics
PDF
The incidence of cardiovascular conditions in patients admitted to hospital with and without COVID-19 in the South-East of Scotland
2024 · A Bularga, F Gruber, et al. · European Heart Journal
A novel dynamic risk score to predict venous thromboembolism (VTE) recurrences after 3 months of anticoagulation in patients with incident VTE and without active cancer
2024 · A Cohen, S Choudhuri, et al. · European Heart Journal
Works count: 40
Citation count: 319
H-index: 10
I10-index: 10
Year
Topic
Type